Huitao Liu
St Paul's Hospital
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3.
Journal: Molecular therapy oncolytics
Published: June 01, 2022
A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice.
Journal: Cancer letters
Published: April 19, 2022
Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model.
Journal: Journal of neuroinflammation
Published: July 26, 2021
Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges.
Journal: Viruses
Published: May 04, 2021
FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Journal: Journal of virology
Published: March 11, 2021
Coxsackievirus B3 targets TFEB to disrupt lysosomal function.
Journal: Autophagy
Published: March 11, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer.
Journal: Molecular therapy oncolytics
Published: February 12, 2021
Autophagy Receptor Protein Tax1-Binding Protein 1/TRAF6-Binding Protein Is a Cellular Substrate of Enteroviral Proteinase.
Journal: Frontiers in microbiology
Published: December 29, 2020
The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy.
Journal: Biochemical and biophysical research communications
Published: November 16, 2020
Coxsackievirus infection induces a non-canonical autophagy independent of the ULK and PI3K complexes.
Journal: Scientific reports
Published: June 18, 2020
Last Updated: 09/26/2026